Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aviandr in Generalized Anxiety Disorder
NCT04598867Phase 3Unknown
- Sponsor
- ChemRar High-Tech Center
- Start
- Dec 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Aviandr in generalized anxiety disorder (GAD), sponsored by ChemRar High-Tech Center. Status: unknown.
02
Drugs
Aviandr
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT04598867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04598867.